Fusion Pharmaceuticals is a clinical-stage oncology company dedicated to advancing next-generation radiopharmaceuticals as precision medicines. By harnessing innovative technologies, Fusion aims to improve cancer treatment outcomes and enhance patient lives through targeted therapeutic approaches.